01
Structured intake
Normalize information into a consistent format that professionals can inspect and validate.
Professional-facing clinical intake infrastructure
Safer, structured clinical intake — with professionals in control.
CelestyxAI is developing professional-facing clinical intake and pre-assessment infrastructure that combines deterministic safeguards, bounded AI assistance, structured outputs and human clinical validation.
Pre-pilot validationHuman-in-the-loop by designFHIR-oriented target architecture
What CelestyxAI is
Infrastructure for the intake layer — not autonomous care.
The product direction is focused on helping healthcare teams capture, structure and review clinical intake information before formal assessment. The model is professional-facing and designed around explicit safeguards, traceability and institutional governance.
02
Deterministic safeguards
Represent safety-critical rules outside the language model and keep them versionable.
03
Auditable AI assistance
Constrain model tasks, validate output structure and preserve relevant traces.
04
Interoperability-oriented
Design structured exchange with FHIR and institutional integration requirements in mind.
Clinical safety
Separate deterministic authority from probabilistic assistance.
CelestyxAI's target architecture is built around a simple premise: a generative model should not be the sole authority for safety-critical clinical policy. Explicit rules, constrained model use, schema validation and professional review are designed as separate layers.
✓
Human clinical validationProfessional review remains explicit in the intended workflow.
✓
TraceabilityRule, model, prompt and output context are designed to be inspectable and versionable.
✓
Bounded AI roleGenerative assistance is scoped to defined tasks rather than unrestricted clinical authority.
✓
Validation before claimsClinical workflow and safety assumptions must be tested before broader deployment.
Pre-pilot validation stage
Seeking clinical and institutional design partners.
Current work is focused on workflow fit, safety assumptions, governance requirements, evaluation endpoints and controlled pilot readiness. CelestyxAI is not currently deployed for autonomous patient use and does not claim prospectively validated clinical outcome improvements.
Research reviews
Design decisions grounded in current clinical-AI evidence.
The research section tracks factual, source-linked work on LLM safety, adversarial evaluation, clinical benchmarks, interoperability and human oversight from 2025 through 2026.
Medical LLM data-poisoning risk
Why conventional benchmark performance can remain reassuring even when medical knowledge has been corrupted.
Clinical text to FHIR
What structured conversion research implies for schema validation and deterministic post-processing.
Safety across the full LLM lifecycle
Why clinical safety must include data, model, workflow, infrastructure, governance and human interaction layers.
Technologies CelestyxAI Inc.
A clinical-AI company being built for institutional scrutiny.
Explore the company, the target architecture, the evidence base and the current validation needs — then contact us if there is a concrete fit.